Feasibility of Implementing Universal Healthcare Coverage in Egypt: A Qualitative Study
Objective: The aim of this study was to assess the applicability of social health insurance (SHI) model as being the equitable right strategy in order to fully implement UHC in Egypt.
Methods: This qualitative study was conducted over a period of 3 months using semi-structured interviews and desk review. A series of interviews were conducted among 20 different stakeholders during six visits. The interviewees were senior experts in a number of national and international organizations concerned with healthcare development. They represented four main groups: Policy makers, service providers, SHI beneficiaries (patients), and NGOs representatives. A framework approach was used to analyse the qualitative data.
Results: Participants identified several factors that affect the implementation of UHC in Egypt based on the strengths and weaknesses of the current Egyptian healthcare system and potential future perspectives. The main themes highlighted were the challenges faced by the existing SHI system, and barriers affecting tax-financed system.
Conclusion: The study provides supportive evidence that SHI is the right equitable strategy provided that it is implemented appropriately. Concomitant with the new health insurance law presented currently for public discussion, an explicit roadmap for SHI reform taking into consideration pressing challenges is required.
Learning Areas:Administration, management, leadership
Provision of health care to the public
Public health or related laws, regulations, standards, or guidelines
Public health or related public policy
Assess the feasibility of universal healthcare coverage in a low-income country
Keyword(s): Health Care Access, Health Care Costs
Qualified on the content I am responsible for because: I have been the principal investigator of this study, as part of my thesis dissertation.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.